BridgeMD
New treatment option for Stoma - Ileostomy
Official title Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1
ClinicalTrials.gov ID: NCT06917963
What this study is testing
What is Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM)?
Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM) is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for stoma - ileostomy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to evaluate if intensified omeprazole therapy can reduce high-output stoma (HOS) in adults undergoing ileostomy formation surgery. The main objectives of the study are: To assess if intensified omeprazole treatment significantly reduces mean daily ileostomy output (ml/24h) during the first three postoperative days compared to standard omeprazole treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older
- Scheduled for elective or emergency surgery requiring end or loop ileostomy formation
- Able and willing to provide written informed consent
- No contraindications to omeprazole use
You likely can't join if
- Pregnancy or lactation
- Known hypersensitivity or allergy to proton pump inhibitors (including omeprazole)
- Conditions preventing accurate measurement of daily ileostomy output
The study team makes the final eligibility decision.
Where it's taking place
- Gdansk, Pomeranian Voivodeship, Poland
- Gdynia, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gdansk, Pomeranian Voivodeship, Poland; Gdynia, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.